AI chatbot for prostate cancer radiation education
Part of Cancer clinical trials.
This study tests an AI chatbot that helps patients understand radiation therapy for prostate cancer. If you are starting radiation treatment at Brigham and Women's Hospital, this chatbot may help answer your questions and support you through your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with prostate cancer.
- You are planning to receive radiation therapy for prostate cancer at Brigham and Women's Hospital.
- You can speak and understand English.
- You are able to give your own consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an Arabic-speaking AI chatbot to provide education and support to women with breast cancer. The goal is to help you better understand your diagnosis and care.
This study tests if an AI tool can improve the safety review of radiation treatment plans for prostate cancer. Patients continue their normal treatment while the AI helps doctors check the plans.
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
This study tests whether an AI chatbot can help thyroid cancer patients understand their surgery and recovery better. You would use the chatbot before and after your scheduled thyroid surgery to answer questions and learn about what to expect.
This study tests a digital avatar that helps you learn about your cancer treatment. It aims to make understanding your treatment easier and more interactive, helping you feel more prepared.
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
Hear when a new Prostate Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.